Adagrasib (Krazati) for NSCLC

Med Lett Drugs Ther. 2023 Jan 23;65(1668):e17-e18. doi: 10.58347/tml.2023.1668f.
No abstract available

Keywords: Krazati; adagrasib; adverse effects; dosage; drug interactions; efficacy; lactation; lung cancer; pregnancy; safety.

MeSH terms

  • Acetonitriles
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Lung Neoplasms* / drug therapy
  • Pyrimidines

Substances

  • adagrasib
  • Pyrimidines
  • Acetonitriles